Results 151 to 160 of about 2,694 (167)
Some of the next articles are maybe not open access.
Hypolipidemic action of phytic acid (IP6): prevention of fatty liver.
Anticancer research, 2000Until recently, most published reports on phytic acid (myo-inositol hexaphosphoric acid, IP6) have focused on the possible decreased mineral bioavailability. Because myo-inositol is known to function as a lipotropic factor, studies in my laboratory were conducted to investigate whether dietary IP6 also reduces excessive liver lipids.
openaire +1 more source
Inositol hexaphosphate (IP6) as an anti-neoplastic and lipid-lowering agent.
Anticancer research, 2000IP6, a major dietary source of inositol phosphates, is a physiological antioxidant with potential to form complexes with cations linked to cell proliferation and hypercholesterolemia. Accordingly, we have examined the action of IP6 on dietary modulation of neoplasia and hyperlipidemia in a Fischer rat model (1, 2).
openaire +1 more source
Fe(III) Mixed IP6@Au NPs with Enhanced SERS Activity for Detection of 4-ATP
Scientific Reports, 2020Wen Gu, Lei Han, Gu Wen
exaly
Effect of inositol hexaphosphate (IP6) on human normal and leukaemic haematopoietic cells
British Journal of Haematology, 2002Giorgio Lambertenghi Deliliers +2 more
exaly
Inositol hexaphosphate (IP6): A novel treatment for pancreatic cancer
Journal of Surgical Research, 2004P. Somasundar +4 more
openaire +1 more source
Absorption and excretion of orally administered inositol hexaphosphate (IP6 or phytate) in humans
BioFactors, 2001F Grases, B M Simonet, Ivana Vucenik
exaly